News

Shares of AbbVie Inc. ABBV slipped 1.64% to $170.16 Monday, on what proved to be an all-around dismal trading session for the ...
We recently published a list of 10 Best Pharma Stocks to Buy for Long Term Growth. In this article, we are going to take a ...
We recently published a list of the 10 High Growth Forever Dividend Stocks to Invest In. In this article, we are going to ...
We recently published a list of 15 Best Large-Cap Value Stocks to Buy as the Recession Hits. In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against other best ...
We recently published a list of Jim Cramer’s Game Plan for Next Week: 25 Stocks in Focus. In this article, we are going to ...
We recently published a list of the 10 Best Dividend Monarchs to Invest in Now. In this article, we are going to take a look ...
In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against other best large-cap value stocks to buy as the recession hits. Goldman Sachs highlighted that equities ...
AbbVie Inc. (NYSE:ABBV – Free Report) – Zacks Research reduced their Q1 2025 earnings per share estimates for AbbVie in a research note issued on Tuesday, April 15th. Zacks Research analyst S.
$50,000 of ABBVIE INC. lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing. This included lobbying on issues like: "Education and legislation related to reform of ...